Exegenesis Bio
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $30M
Investors
- 6
About Exegenesis Bio
Founded in 2019 and based in Pennsylvania, US, Exegenesis Bio Inc. operates as a medical health company that develops and manufacture gene therapy drugs.
Who invested in Exegenesis Bio
6 investors across 2 rounds
See all investors in Exegenesis Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exegenesis Bio
Who invested in Exegenesis Bio?
Exegenesis Bio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exegenesis Bio raised?
Exegenesis Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Exegenesis Bio last raise money?
Exegenesis Bio's most recent round on record is a Series B, in Aug 2020.
What does Exegenesis Bio do?
Founded in 2019 and based in Pennsylvania, US, Exegenesis Bio Inc.
Where is Exegenesis Bio headquartered?
Exegenesis Bio is headquartered in US.
Which VCs invest in companies like Exegenesis Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Exegenesis Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Exegenesis Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.